Homegrown pharma major Cipla Ltd has acquired brand name and trademark rights for Vysov for anti-diabetic drug Vildagliptin for the Indian market from Novartis, the company announced recently. However, it Read More
Cipla acquires brand, trademark rights for anti-diabetic drug Vysov in India
